Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Sigyn Therapy
Therapeutic Opportunities
Overview
Sepsis
Virus-induced Cytokine Storm
Bacteria-induced Cytokine Storm
Acute Respiratory Distress Syndrome
Hepatic Encephalopathy
Bridge-To-Liver Transplant
News & Media
Press Releases
Presentations
Resources
Media
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact
CEO Notes
Financial Results
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
2021
Q2 2021
Quarter Ended Jun 30, 2021
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q1 2021
Quarter Ended Mar 31, 2021
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2020
FY 2020
Fiscal Year Ended Dec 31, 2020
10-K
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q3 2020
Quarter Ended Sep 30, 2020
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Email Alerts
Contacts
RSS News Feed
